欢迎使用我们的服务!
限时优惠,立即购买享受折扣
24小时客服在线,随时为您服务
优质产品,值得信赖
顶 置

NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma

NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma

Final draft guidance recommends D‑VRd on the NHS in England and Wales